Concepedia

Publication | Open Access

Phase I evaluation of AB928, a novel dual adenosine receptor antagonist, combined with chemotherapy or AB122 (anti-PD-1) in patients (pts) with advanced malignancies

DOIFull Paper Access

18

Citations

0

References

2019

Year

John D. Powderly, Alexander I. Spira, Rocío Gutiérrez, Daniel DiRenzo, Akshata R. Udyavar, Joyson Karakunnel, Aimee Rieger, Jill Colabella, Dominic W. Lai, P. de Souza
Annals of Oncology

No additional data available for this publication yet. Check back later!